Joseph O. Sexton, Ph.D.
Affiliations: | 2009 | Ecology | Duke University, Durham, NC |
Area:
Ecology Biology, Physical Geography, Remote SensingGoogle:
"Joseph Sexton"Parents
Sign in to add mentorDean L Urban | grad student | 2009 | Duke | |
(Vertical structure, horizontal cover, and temporal change of the North Carolina Piedmont (1985--2005).) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Neigh CSR, Montesano PM, Sexton JO, et al. (2025) Russian forests show strong potential for young forest growth. Communications Earth & Environment. 6: 71 |
Montesano PM, Frost M, Li J, et al. (2024) A shift in transitional forests of the North American boreal will persist through 2100. Communications Earth & Environment. 5: 290 |
Gagné TO, Reygondeau G, Jenkins CN, et al. (2020) Towards a global understanding of the drivers of marine and terrestrial biodiversity. Plos One. 15: e0228065 |
Ikdahl E, Rollefstad S, Sexton J, et al. (2020) Thu0123 Diabetes Mellitus And Cardiovascular Risk Management In Patients With Rheumatoid Arthritis In A Large International Audit Annals of the Rheumatic Diseases. 79: 276-277 |
Christensen IE, Lillegraven S, Sexton J, et al. (2020) AB0760 SERIOUS INFECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS TREATED WITH TNFi: DATA FROM THE NOR-DMARD STUDY. Annals of the Rheumatic Diseases. 79: 1677-1678 |
Rollefstad S, Ikdahl E, Sexton J, et al. (2020) Op0121 Management Of Dyslipidaemia And Hypertension In Patients With Rheumatoid Arthritis – Data From 19 Countries Annals of the Rheumatic Diseases. 79: 80-80 |
Hammer HB, Michelsen B, Sexton J, et al. (2020) Thu0129 Sleep Disturbance And Low Inflammation Predict A Pattern Of Chronic Fatigue In Actively Treated Patients With Established Ra. Annals of the Rheumatic Diseases. 79: 279-280 |
Lillegraven S, Sundlisæter NP, Aga AB, et al. (2020) Sat0148 Tapering Of Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs In Sustained Rheumatoid Arthritis Remission: Results From A Randomized Controlled Trial Annals of the Rheumatic Diseases. 79: 1012-1013 |
Lillegraven S, Sundlisæter NP, Aga AB, et al. (2020) Op0019 Stable Versus Tapered And Withdrawn Treatment With Tumor Necrosis Factor Inhibitor In Rheumatoid Arthritis Remission (Arctic Rewind): A Randomised, Open-Label, Phase 4, Non-Inferiority Trial Annals of the Rheumatic Diseases. 79: 14-15 |
Syversen SW, Goll GL, Jørgensen KK, et al. (2020) Op0017 Therapeutic Drug Monitoring Compared To Standard Treatment Of Patients Starting Infliximab Therapy: Results From A Multicentre Randomised Trial Of 400 Patients Annals of the Rheumatic Diseases. 79: 12-12 |